Stock listing

PFE Stock Price, News, Filings & Events — Pfizer, Inc.

Selected listing: PFE · TSX · CAD · CA

This page tracks Pfizer, Inc.'s PFE:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PFE:TSX. PFE:TSX is the stock-level entry point for investors researching Pfizer, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pfizer, Inc. is a leading global biopharmaceutical company based in America, known for its innovative medicines and vaccines. With a market capitalization of approximately $142.77 billion, Pfizer focuses on developing treatments across various therapeutic areas. The company is committed to advancing healthcare through scientific research and development.

PFE:TSXCADCAUpdated August 28, 2026
Pfizer, Inc. logo
Ticker
PFE:TSX
Asset type
Stock
Market cap
$159.36B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TSX
Currency
CAD

Pfizer, Inc. PFE:TSX stock context

This page tracks Pfizer, Inc.'s PFE:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PFE:TSX. PFE:TSX is the stock-level entry point for investors researching Pfizer, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pfizer, Inc. is a leading global biopharmaceutical company based in America, known for its innovative medicines and vaccines. With a market capitalization of approximately $142.77 billion, Pfizer focuses on developing treatments across various therapeutic areas. The company is committed to advancing healthcare through scientific research and development.

Latest news from Pfizer, Inc.

All Pfizer, Inc. news →

Pfizer, Inc. earnings calls

Research Pfizer, Inc.

Alternate listings